Consolidated Balance Sheets (Current Period Unaudited) - USD ($)	Sep. 30, 2018	Jun. 30, 2018
Current assets:
Cash	$ 176,412	$ 22,013
Prepaid expenses	11,014	7,474
Deposits and other receivables	1,000	1,000
Total current assets	188,426	30,487
Property and equipment, net (Note 3)	1,012	1,448
Total assets	189,438	31,935
Current liabilities:
Accounts payable and accrued expenses	644,428	719,633
Deferred compensation (Note 4)	523,628	421,641
Loan payable and accrued interest (Note 5)	9,091,113	9,028,983
Total current liabilities	10,291,069	10,201,657
Convertible notes payable - affiliates (Note 6)	3,556,473	3,525,216
Total liabilities	13,847,542	13,726,873
Deficit:
Common stock, no par value, 100,000,000 shares authorized, 26,996,148 and 25,939,892 shares issued, respectively; 26,291,839 and 25,235,583 shares outstanding, respectively
Additional paid-in capital	109,424,707	108,117,330
Subscription receivable - affiliates (Note 7)	(504,650)	(174,650)
Accumulated deficit	(122,629,330)	(121,691,956)
Total Bion’s stockholders’ deficit	(13,709,273)	(13,749,276)
Noncontrolling interest	51,169	54,338
Total deficit	(13,658,104)	(13,694,938)
Total liabilities and deficit	189,438	31,935
Series B Preferred Stock [Member]
Current liabilities:
Series B Redeemable Convertible Preferred stock, $0.01 par value, 50,000 shares authorized; 200 shares issued and outstanding, liquidation preference of $34,500 and $34,000, respectively (Note 7)	31,900	31,400
Series A Preferred Stock [Member]
Deficit:
Preferred stock
Series C Preferred Stock [Member]
Deficit:
Preferred stock